Previous studies have shown that bredigite (Ca7MgSi4O16) bioceramics possessed excellent biocompatibility, apatite-mineralization ability and mechanical properties. In this paper, the bredigite coating on Ti-6Al-4 V substrate was prepared by plasma spraying technique. The main compositions of the coating were bredigite crystal phase with small parts of amorphous phases. The bonding strength of the coating to Ti-6Al-4 V substrate reached 49.8 MPa, which was significantly higher than that of hydroxyapatite coating and other silicate-based bioceramic coatings prepared by same method. After immersed in simulated body fluid for 2 days, a distinct apatite layer was deposited on the surface of bredigite coating, indicating that the prepared bredigite coating has excellent apatite-mineralization ability. The prepared bredigite coating supported the attachment and proliferation of rabbit bone marrow stem cells. The proliferation level of bone marrow stem cells was significantly higher than that on the hydroxyapatite coating. Our further study showed that the released SiO44– and Mg2+ ions from bredigite coating as well as the formed nano-apatite layer on the coating surface might mainly contribute to the improvement of cell proliferation. The results indicated that the bredigite coating may be applied on orthopedic implants due to its excellent bonding strength, apatite mineralization and cytocompatibility.
FuQSHongYLLiuXG. A hierarchically graded bioactive scaffold bonded to titanium substrates for attachment to bone. Biomaterials2011; 32: 7333–7346.
2.
ZhengXHuangMDingC. Bond strength of plasma-sprayed hydroxyapatite/Ti composite coatings. Biomaterials2000; 21: 841–849.
3.
NaganoMNakamuraTKokuboT. Differences of bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating. Biomaterials1996; 17: 1771–1777.
4.
LinDYWangXX. A novel method to synthesize hydroxyapatite coating with hierarchical structure. Colloids Surf B: Biointerfaces2011; 82: 637–640.
5.
OonishiHHenchLLWilsonJ. Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res1999; 44: 31–43.
6.
KhorKAGuYWPanD. Microstructure and mechanical properties of plasma sprayed HA/YSZ/Ti-6Al-4V composite coatings. Biomaterials2004; 25: 4009–4017.
7.
YangCWLeeTMLuiTS. A comparison of the microstructural feature and bonding strength of plasma-sprayed hydroxyapatite coatings with hydrothermal and vacuum post-heat treatment. Mater Trans2005; 46: 709–715.
8.
TaoSYJiHDingCX. Effect of vapor-flame treatment on plasma sprayed hydroxyapatite coatings. J Biomed Mater Res2000; 52: 572–575.
9.
XueWCTaoSYLiuXY. In vivo evaluation of plasma sprayed hydroxyapatite coatings having different crystallinity. Biomaterials2004; 25: 415–421.
10.
LuYPSongYZZhuRF. Factors influencing phase compositions and structure of plasma sprayed hydroxyapatite coatings during heat treatment. Appl Surf Sci2003; 206: 345–354.
11.
ChenYMLuYPLiMS. Surface changes of plasma sprayed hydroxyapatite coatings before and after heat treatment. Surf Eng2006; 22: 462–467.
12.
ChenCZWangDGBaoQH. Effects of technological parameters on the microstructure of laser remelted hydroxyapatite (HA) coatings. J Phys D: Appl Phys2006; 39: 1169–1173.
GuYWKhorKAPanD. Activity of plasma sprayed yttria stabilized zirconia reinforced hydroxyapatite/Ti-6Al-4V composite coatings in simulated body fluid. Biomaterials2004; 25: 3177–3185.
19.
ChenCCHuangTHKaoCT. Characterization of functionally graded hydroxyapatite/titanium composite coatings plasma-sprayed on Ti alloys. J Biomed Mater Res B2006; 78B: 146–152.
20.
LeeTMYangCYChangE. Comparison of plasma-sprayed hydroxyapatite coatings and zirconia-reinforced hydroxyapatite composite coatings: in vivo study. J Biomed Mater Res A2004; 71A: 652–660.
21.
ChouBYChangE. Interface investigation of plasma-sprayed hydroxyapatite coating on titanium alloy With ZrO2 intermediate layer as bond coat. Scrip Mater2001; 45: 487–493.
22.
LuYPLiMSLiST. Plasma-sprayed hydroxyapatite plus titania composite bond coat for hydroxyapatite coating on titanium substrate. Biomaterials2004; 25: 4393–4403.
23.
ChouBYChangE. Plasma-sprayed zirconia bond coat as an intermediate layer for hydroxyapatite coating on titanium alloy substrate. J Mater Sci Mater Med2002; 13: 589–595.
24.
GomesPSBotelhoCLopesMA. Evaluation of human osteoblastic cell response to plasma-sprayed silicon-substituted hydroxyapatite coatings over titanium substrates. J Biomed Mater Res2010; 94B: 337–346.
25.
SilvaHMMateescuMDamiaC. Importance of dynamic culture for evaluating osteoblast activity on dense silicon-substituted hydroxyapatite. Colloids Surf B: Biointerfaces2010; 80: 138–144.
26.
SilvaHMMateescuMPoncheA. Surface transformation of silicon-doped hydroxyapatite immersed in culture medium under dynamic and static conditions. Colloids Surf B: Biointerfaces2010; 75: 349–355.
27.
XueWHosickHLBandyopadhyayA. Preparation and cell-materials interactions of plasma sprayed strontium-containing hydroxyapatite coating. Surf Coat Technol2007; 201: 4685–4693.
28.
LiuXYDingCX. Characterization of plasma sprayed wollastonite powder and coatings. Surf Coat Technol2002; 153: 173–177.
29.
DuHWeiZWangH. Surface microstructure and cell compatibility of calcium silicate and calcium phosphate composite coatings on Mg-Zn-Mn-Ca alloys for biomedical application. Colloids Surf B: Biointerfaces2011; 83: 96–102.
WuCTRamaswamyYLiuXY. Plasma-sprayed CaTiSiO(5) ceramic coating on Ti-6Al-4V with excellent bonding strength, stability and cellular bioactivity. J R Soc Interface2009; 6: 159–168.
33.
LiKYuJMXieYT. Chemical stability and antimicrobial activity of plasma sprayed bioactive Ca(2)ZnSi(2)O(7) coating. J Mater Sci Mater Med2011; 22: 2781–2789.
34.
XieYZhaiWChenL. Preparation and in vitro evaluation of plasma-sprayed Mg2SiO4 coating on titanium alloy. Acta Biomater2009; 5: 2331–2337.
35.
XiaLZhangZChenL. Proliferation and osteogenic differentiation of human periodontal ligament cells on akermanite and beta-tcp bioceramics. Eur Cells Mater2011; 22: 68–83.
36.
HuangYJinXZhangX. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials2009; 30: 5041–5048.
37.
YiDWuCMaX. Preparation and in vitro evaluation of plasma-sprayed bioactive akermanite coatings. Biomed Mater2012; 7: 065004–065004.
38.
WuCChangJWangJ. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic. Biomaterials2005; 26: 2925–2931.
39.
WuCChangJ. Synthesis and in vitro bioactivity of bredigite powders. J Biomater Appl2007; 21: 251–263.
40.
WuCTChangJZhaiWY. A novel bioactive porous bredigite (Ca7MgSi4O16) scaffold with biomimetic apatite layer for bone tissue engineering. J Mater Sci Mater Med2007; 18: 857–864.
41.
ZhouYWuCZhangX. The ionic products from bredigite bioceramics induced cementogenic differentiation of periodontal ligament cells via activation of the Wnt/beta-catenin signalling pathway. J of Mater Chem B2013; 1: 3380–3389.
TavangarianFEmadiR. Mechanism of nanostructure bredigite formation by mechanical activation with thermal treatment. Mater Lett2011; 65: 2354–2356.
44.
ZhaoXQAnYLChenJM. Properties of Al(2)O(3)-40 wt.% ZrO(2) composite coatings from ultra-fine feedstocks by atmospheric plasma spraying. Wear2008; 265: 1642–1648.
45.
KokuboTTakadamaH. How useful is SBF in predicting in vivo bone bioactivity?Biomaterials2006; 27: 2907–2915.
46.
GrecoSJLiuKRameshwarP. Functional similarities among genes regulated by Oct4 in human mesenchymal and embryonic stem cells. Stem Cells2007; 25: 3143–3154.
47.
LiHYHuJZhaoS. Comparative study of the effect of baicalin and its natural analogs on neurons with oxygen and glucose deprivation involving innate immune reaction of TLR2/TNF alpha. J Biomed Biotechnol2012: 267890.
48.
LiuXChuPKDingC. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater Sci Eng R: Reports2004; 47: 49–121.
49.
OhIKNomuraNChibaA. Microstructures and bond strengths of plasma-sprayed hydroxyapatite coatings on porous titanium substrates. J Mater Sci Mater Med2005; 16: 635–640.
50.
HayakawaSTsuruKOhtsukiC. Mechanism of apatite formation on a sodium silicate glass in a simulated body fluid. J Am Ceram Soc1999; 82: 2155–2160.
51.
LiuXDingCWangZ. Apatite formed on the surface of plasma-sprayed wollastonite coating immersed in simulated body fluid. Biomaterials2001; 22: 2007–2012.
52.
MaJChenCZWangDG. Synthesis, characterization and in vitro bioactivity of magnesium-doped sol-gel glass and glass-ceramics. Ceram Int2011; 37: 1637–1644.
53.
MirhadiSMTavangarianFEmadiR. Synthesis, characterization and formation mechanism of single-phase nanostructure bredigite powder. Mater Sci Eng C2012; 32: 133–139.
54.
HouXNYinGFChenXC. Effect of akermanite morphology on precipitation of bone-like apatite. Appl Surf Sci2011; 257: 3417–3422.
55.
ChoiJBogdanskiDKollerM. Calcium phosphate coating of nickel-titanium shape-memory alloys. Coating procedure and adherence of leukocytes and platelets. Biomaterials2003; 24: 3689–3696.
56.
ChouYFHuangWBDunnJCY. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials2005; 26: 285–295.
57.
ChouYFDunnJCYWuBM. In vitro response of MC3T3-E1 preosteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B2005; 75B: 81–90.
58.
LiuGWuCTFanW. The effects of bioactive akermanite on physiochemical, drug-delivery, and biological properties of poly(lactide-co-glycolide) beads. J Biomed Mater Res B2011; 96B: 360–368.
59.
LiuQHCenLYinS. A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics. Biomaterials2008; 29: 4792–4799.
60.
BotelhoCMBrooksRABestSM. Human osteoblast response to silicon-substituted hydroxyapatite. J Biomed Mater Res A2006; 79A: 723–730.
61.
ThianESHuangJBestSM. The response of osteoblasts to nanocrystalline silicon-substituted hydroxyapatite thin films. Biomaterials2006; 27: 2692–2698.
